跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 19,200 条关于
“CD3/EpCAM bispecific antibody”
全部
19,200
临床试验
9,818
药物
3,134
机构
77
资讯
6,171
5个月前
SBP Group's M701 Bispecific Antibody Receives NDA Acceptance for Malignant Ascites Treatment
5个月前
Mabwell Achieves Global First with NMPA Acceptance of Novel LILRB4/CD3 Bispecific Antibody for Blood Cancers
去年
Pharmanovia In-Licenses Catumaxomab for Malignant Ascites Treatment
去年
BioAtla's BA3182 Shows Tumor Shrinkage Across Multiple Cancer Types in Phase 1 Trial
去年
CHMP Recommends Approval of Lindis Biotech's Korjuny (catumaxomab) for Malignant Ascites
去年
Leads Biolabs' LBL-034 Receives FDA Orphan Drug Designation for Multiple Myeloma
10个月前
BioAtla Secures $22.5 Million Flexible Financing to Support Operations While Pursuing Strategic Partnership
3个月前
Latent EBV Infection Enhances Anti-CD3 Antibody Efficacy in Type 1 Diabetes
2年前
Bispecific Antibody-Drug Conjugates Show Promise in Solid Tumor Treatment
6个月前
BioAtla Initiates Strategic Review Process Amid Major Restructuring and 70% Workforce Reduction
第 1 页，共 618 页
上一页
下一页
